Financial Gravity Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Financial Gravity Asset Management’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-100	Closed	-$8K	–	1414
2019 Q4	$8K	Hold	100	–	–	0.01%	1229
2019 Q3	$5K	Hold	100	–	–	﹤0.01%	717
2019 Q2	$5K	Hold	100	–	–	﹤0.01%	708
2019 Q1	$5K	Buy	+100	New	+$4.91K	﹤0.01%	711
2018 Q3	$4K	Hold	100	–	–	﹤0.01%	813
2018 Q2	$5K	Buy	+100	New	+$4.55K	﹤0.01%	787

Other funds holding GBT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Financial Gravity Asset Management's GBT Position: Q1 2020 in Review

Financial Gravity Asset Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q1 2020, closing a stake of 100 shares — an estimated $8K sold.

Financial Gravity Asset Management first reported a position in GBT in Q2 2018 and held it in 6 quarters. The position peaked at $8K in Q4 2019. 220 funds tracked by Wall St. Rank hold GBT as of Q1 2020.

Financial Gravity Asset Management reported no remaining Global Blood Therapeutics, Inc. position as of Q1 2020 after selling out during the quarter.
Financial Gravity Asset Management sold 100 Global Blood Therapeutics, Inc. shares in Q1 2020, an estimated $8K.
Financial Gravity Asset Management first reported a position in Global Blood Therapeutics, Inc. in Q2 2018 and held it in 6 quarters.
Financial Gravity Asset Management's Global Blood Therapeutics, Inc. position peaked at $8K in Q4 2019.
220 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q1 2020.

Based on Financial Gravity Asset Management's 13F filing for Q1 2020, filed 12 May 2020.